Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
about
Use of natalizumab in multiple sclerosis: current perspectives.Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot studyMultiple sclerosis animal models: a clinical and histopathological perspective.Efficiency of antibody therapy in demyelinating diseases.Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.Advances and insights into neurological practice 2016-17.
P2860
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@en
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@nl
type
label
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@en
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@nl
prefLabel
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@en
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@nl
P2093
P2860
P356
P1476
Effect of natalizumab on brain ...... lerosis patients over 5 years.
@en
P2093
B Weinstock-Guttman
D Hojnacki
D P Ramasamy
J Hagemeier
R Zivadinov
P2860
P304
P356
10.1111/ENE.12992
P577
2016-03-21T00:00:00Z